Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08BDI
|
||||
Former ID |
DNC005459
|
||||
Drug Name |
N-(5-o-Tolyl-furan-2-carbonyl)-guanidine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527509] | ||
Structure |
Download2D MOL |
||||
Formula |
C13H13N3O2
|
||||
Canonical SMILES |
CC1=CC=CC=C1C2=CC=C(O2)C(=O)N=C(N)N
|
||||
InChI |
1S/C13H13N3O2/c1-8-4-2-3-5-9(8)10-6-7-11(18-10)12(17)16-13(14)15/h2-7H,1H3,(H4,14,15,16,17)
|
||||
InChIKey |
ACPWXEWIQCMXFE-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sodium/hydrogen exchanger 1 | Target Info | Inhibitor | [527509] | |
Pathway Interaction Database | Endothelins | ||||
RhoA signaling pathway | |||||
ErbB1 downstream signaling | |||||
Signaling mediated by p38-alpha and p38-beta | |||||
Reactome | Hyaluronan uptake and degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.